The Catalyst Issue 9 | Winter 2011 | Page 18

Triple Threat continued what separates it from other cancer drugs. Other drugs either kill the tumor or act as a vaccine to boost the immune system’s ability to fight cancer, but they don’t do both. Support from Pink Glove Fighters When breast cancer survivors in Central Texas heard about the drug’s potential, they formed a group specifically to raise funds for Dr. Asea’s research and hasten it toward clinical trials. “They sort of adopted me,